1. P-214Bevacizumab combined with 1st line chemotherapy in elderly patients with metastatic colorectal cancer: Are there good prognostic indicators?. (20th June 2018) Authors: Borges, C; Simões, J; Lemos, C; Fernandes, C; Sarmento, C; Damasceno, M; Almeida, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-214Bevacizumab combined with 1st line chemotherapy in elderly patients with metastatic colorectal cancer: Are there good prognostic indicators?. (20th June 2018) Authors: Borges, C; Simões, J; Lemos, C; Fernandes, C; Sarmento, C; Damasceno, M; Almeida, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P-267The prognostic impact of sidedness in RAS wild-type colorectal cancer. (20th June 2018) Authors: Tavares, N; Costa, A; Almeida, D; Meireles, S; Fernandes, C; Rey, C; Sarmento, C; Damasceno, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P-367Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in malignant peritoneal disease: a review on outcomes for colorectal cancer. (2nd July 2019) Authors: Simões, J; Fernandes, C; Borges, C; Melo, R; Sarmento, C; Meireles, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗